On rare occasions, alloimmunization due to minor erythrocyte antigens
may cause severe hemolytic disease requiring exchange transfusion.
Study Published in Transfusion Finds BeadChip(TM) Test for Human Erythrocyte Antigen
Mutation Screening As Accurate As Current More Labor Intensive Methods
Flow cytometry was used to characterize cells and to evaluate changes in erythrocyte antigen
Food and Drug Administration today approved the Immucor PreciseType Human Erythrocyte Antigen
(HEA) Molecular BeadChip Test the first FDA-approved molecular assay used in transfusion medicine to assist in determining blood compatibility.
Contract award: acquisition of "monoclonal reagents for determining erythrocyte antigens
into the oab (oab serum - clone x)".